Pamela Bradt, MD, MPH
Chief Scientific Officer
Pam is Chief Scientific Officer at the Institute for Clinical and Economic Review. In this capacity, she is responsible for leading the organization’s research enterprise, including systematic evidence reviews and health economic modeling. As a member of ICER’s Senior Management Team, Pam also helps evolve ICER’s methods of value assessment and expands the application of our work.
Before joining ICER, Pam served as Chief Medical Officer for a biopharmaceutical company focused on rare diseases, and she has extensive experience with both large and midsize global pharmaceutical companies in a variety of disease areas. Prior to joining industry, she worked in academic medicine.
Pam received a BA in French and psychology from Kansas State University, her MD from the University of Kansas School of Medicine in Kansas City, and her MPH from the University of Texas School of Public Health in Houston. She completed her residency in pediatric medicine at the University of Kansas in Kansas City. Dr. Bradt received the Herbert C. Miller Award for Outstanding Research in Pediatrics, and she was nominated for Physician of the Year in Houston.